Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Renaissance Capital Greenwich Fund (NY: IPOS)
28.00 USD  -0.19 (-0.67%)
Official Closing Price  /  Updated: 7:59 PM EDT, Jun 5, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Renaissance Capital Greenwich Fund
Sector
Exchange Traded NY
Net Assets 2.80M
Inception Date
Related Funds
Quote
Price 28.00
Volume 3,800
Last Trade Jun 05, 7:59pm
Change (%)
-0.19 (-0.67%)
Prev. Close 28.18
YTD %
+13.36%
Dividend Yield 0.75%
Performance
YTD
+3.30 (13.36%)
1 Month
+4.55 (19.38%)
3 Month
+3.23 (13.06%)
6 Month
+4.61 (19.69%)
1 Year
+6.88 (32.55%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
American Well Files For IPO As Pandemic Leads To Telehealth Demand Surge
American Well confidentially filed for an initial public offering with the United States Securities and Exchange Commission earlier this ... Read More
from Benzinga
Top News
More News
Amwell confidentially files for IPO amid surging demand for telemedicine
Amwell, a provider of telehealth services formerly known as American Well, is looking to go public in the coming months, sources tell CNBC. Read More
from CNBC.com News
Meet the newest multibillionaire: Nikola's founder is now worth $4.6 billion after IPO
Trevor Milton's newfound fortune is the latest vindication for the Utah-born college dropout, who founded Nikola at the age of 29 after talking to truckers in the North Dakota oil fields. Read More
from CNBC.com News
ZoomInfo IPO: What You Need To Know
If you’re looking for fresh exposure to artificial intelligence and machine learning, this B2B databasewants your ... Read More
from Benzinga
ZoomInfo Raises $935M In Its IPO, Beating Market Expectations
ZoomInfo on Wednesday raised $935 million in its initial public offering. The business database provider sold 44.5 million shares ... Read More
from Benzinga
New Leaf Ventures Closes Second And Final Tranche Of IPO
Health care investment firm New Leaf Ventures Inc. (CSE: NLV) announced Wednesday the closing of a second tranche of its initial public ... Read More
from Benzinga
Warner Music CEO On IPO: Music Is The 'Only Global Language'
Warner Music Group Corp. priced its 77-million-share IPO at $25 per share, and the stock opened higher Wednesday at $27. As a ... Read More
from Benzinga
Chinese EV Maker Xpeng Motors Seeks $500M US IPO: Report
Electric vehicle pioneer Tesla Inc (NASDAQ: TSLA) might be getting more tough competition from the Chinese EV market. Nio Inc – ... Read More
from Benzinga
Warner Music IPO: What You Need To Know
Superfans of Lizzo, Ed Sheeran and Cardi B can now cash in on their idols’ latest hits by investing in this newly public ... Read More
from Benzinga
The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Warner Music Set To Go Public Today, In Anticipated Largest US IPO Of The Year
Warner Music is set to list at the Nasdaq Stock Market on Wednesday. Warner Music Could Kickstart A String Of IPOs This Year The ... Read More
from Benzinga
The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight
Biotech stocks could not sustain the uptrend in the holiday-shortened week, even as traders digested COVID-19-related news flow, ... Read More
from Benzinga
PreMarket Prep Stock Of The Day: GAN Limited
Benzinga'sPreMarket Prepairs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders ... Read More
from Benzinga
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.